Modalis Therapeutics Corp (4883) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	726.27M	346.41M	293.75M	606.25M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	56.81M	24.56M	48.78M	40.22M
Operating expense	783.08M	395.97M	342.52M	610.48M
Total operating expenses	783.08M	395.97M	342.52M	610.48M
Operating income	-783.08M	-395.97M	-342.52M	-610.48M
Other non operating income	-2.52M	11.62M	5.81M	29.19M
EBT including unusual items	-780.69M	-350.53M	-323.15M	-579.85M
EBT excluding unusual items	-779.04M	-350.77M	-322.51M	-596.49M
Income tax expense	625.00K	-300.00K	582.00K	5.42M
Effective tax rate	-0.08%	0.09%	-0.18%	-0.93%
Other operating expenses	-	25.00M	-	-
Net income	-781.32M	-350.23M	-323.73M	-585.27M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	2.53M	439.00K	2.25M	-
Interest expense	-7.92M	-839.00K	-2.34M	-6.91M
Net interest expenses	-5.39M	-400.00K	-86.00K	-6.91M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance